Abstract. FG human pancreatic carcinoma cells use integrin otv/35 as their primary vitronectin receptor since they fail to express integrin o~v/33. These cells are unable to form focal contacts, spread, or migrate on vitronectin but readily do so on collagen in a/31 integrin-dependent manner. Transfection of FG cells with a eDNA encoding the integrin t53 subunit results in the surface expression of a functional integrin otv/33 heterodimer providing these cells with novel adhesive and biological properties. Specifically, FG cells expressing 133 acquire the capacity to attach and spread on vitronectin as well as fibrinogen with/33 localization to focal contacts. Moreover, these cells gain the capacity to migrate through a porous membrane in response to either vitronectin or fibrinogen. These results demonstrate that the/33 and/35 integrin subunits when associated with oev, promote distinct cellular responses to a vitronectin extracellular environment.
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I
NTEGRINS are a family of cell surface molecules mediating diverse biological events involving cell-matrix as well as cell-cell interactions. The term integrin denotes a functional linkage between the extracellular matrix and the cells' interior, thus providing cellular responsiveness to the extracellular environment (Tamkun et al., 1986; Buck and Horowitz, 1987) . Integrin-llgand specificity is conferred by the subunit composition of the integrin heterodimer (,v/3) complex (Hynes, 1987; Ruoslahti and Pierschbacher, 1987) . In some cases, a given integrin heterodimer may recognize multiple ligands or multiple integrins may recognize common ligands. The biological function underlying this intrinsic multiplicity and redundancy in ligand-integrin interaction is not well understood.
The av integrin subunit is unique in that it associates with more than two/3 subunits including/31 Vogel et al., 1990) , t33 (Cheresh and Spiro, 1987; Cheresh et al., 1989b) , /35 (Cheresh et al., 1989a) , /56 (Sheppard et al., 1990) , and/38 (Moyle et al., 1991) . While the c~v/31 and otv/35 heterodimers appear to be restricted in their ligand binding specificity, the wr heterodimer interacts with multiple ligands in an Arg-Gly-Asp (RGD)-dependent manner (Cheresh, 1987; Cheresh and Spiro, 1987; Charo et al., 1987) . We recently reported that while both w,,/33 and otv/35 contribute to melanoma and carcinoma cell adhesion to vitronectin, only o~v/33 was found to cluster into focal contacts. In contrast, otv/35 failed to localize to focal contacts but rather clustered in small patches distributed over much of the cell surface (Wayner et al., 1991) . Focal contacts, or adhesion plaques are structures which traverse the plasma membrane linking the extracellular substrate with components of the cytoskeleton (Burridge et al., 1988; . The ability of a cell to form focal contacts correlates with its ability to assemble an organized cytoskeleton which, in turn, is prerequisite for cell spreadhag and migration (Dejana et al., 1987) . Thus o~v/33 and otv/35 exhibit different responses upon binding immobilized vitronectin and thereby have the potential to mediate distinct signals within the cell.
To investigate the biological role of these integrins we identified a cell line, FG human carcinoma (Cheresh et al., 1989) , which fails to express o~v/33 and thus adheres to vitronectin in an c~v/35-dependent manner. These cells are unable to spread or migrate on this ligand. Upon transfection of FG cells with a eDNA encoding the human/33 integrin subunit we could express ,v/33 in a functional form resulting in the ability of these cells to spread and migrate on a vitronectin or fibrinogen matrix. Thus our results demonstrate that two homologous integrins, expressed on the same cell and recognizing the same ligand, can promote distinct signals potentiating diverse biological activities in response to a given extracellular matrix.
Materials and Methods

Cells and Cell Culture
FG is a human pancreatic carcinoma cell line that fails to express mRNA for the ~3 intngrin subunit (Cheresh et al., 1989) . FG-A and FG-B are two stably U'ansfected sub-lines: FG-B, is transfected with a full length eDNA encoding human/~3 gene; FG-A is a subline, transfected with vector alone. M21 human melanoma cells wore a gift from Dr. Donald Morton (Department of Surgery, University of California, Los Angeles, CA). All cells wore grown in RPMI 1640 with 10% FBS, 50/~g/rni gentamycin, and tested free from mycoplesma during these studies.
Antibodies
Integrin specific mAbs LM609 (avB3; Cheresh and Spiro, t987), LM142 (a'v; Cheresh and Harper, 1987) , P4C10 (/~1; Carter et al., 1990) ; LM534 (B1; Wayner et al., 1991) , and P3G2 (ave5; Wayner et al., 199t) were affinity purified from ascites on protein A-Sepbarose (AffiGel protein A MAPS H Kit; Bio-Rad Laboratories, Richmond, CA). mAb AP3 was a generous gift from Dr. Peter Newman (Blood Center of Southwestern Wisconsin, Milwaukee, WI).
Adhesive Ligands
Vitronectin was prepared as described by Yatohgo et al. (1988) , Fibrinogen was purified according to the method of Felding-Habermann et al. (1992) . Collagen type I was purchased from Collaborative Research (New Bedford, MA).
cDNA Transfection of FG Cells
Full length eDNA encoding the human 83 integrin subunit, kindly provided by Dr. Larry Fitzgerald (University of Utah, Salt Lake City, UT) was ligated into the expression vector peDNAineo (Invitrogen, San Diego, CA) and transfected into FG carcinoma cells using the lipofectin protocol (Calbiochem-Behring Corp., La Jolla, CA). In brief, sub-confluent adherent cells were incubated with 2 ptg eDNA and 40 t~g lipofectin for 24 h, allowed to recover for 48 h before selection in neomycin for 2 wk at a concentrafion of 500 ~g/ml. Neomycin-resistant cells were expanded arid the celt surface expression of ~,vB3 analyzed by flow cytometry using the ~3 complex-specific antibody, LM609. Immunoreactive cells were enriched with four consecutive rounds of fluorescence-activated cell sorting, after which we observed stable surface expression of avB3 in ~40% of the trans. fected cell line. Positive (fiG-B) and negative (FG-A) transfectant populations were recovered and maintained in vitro.
Cell Surface Labeling and Immunoprecipitation
Cell surface proteins were i2SI-labeled using lactoperoxidase as previously described (Cheresh et al., 1989) . Radiotabeled cells were lysed in R1PA buffer (10 mM "Iris, pH 7.2, 150 mM NaCI, containing 1% Triton X-100, 1% deoxycholate, 0.1% SDS with 1% aprotinin (No. A6279; Sigma Chemical Co., St. Louis, MO) and 1 mM PMSF prior to immunoprecipitation with integrin-specific mAbs coupled to Sepharose (Pharmacia, Uppsala, Sweden) as described (Cheresh et al., 1989) . Immunoprecipitates were analyzed by SDS-PAGE (Laemmli, 1970) under non-reducing conditions on 7.5% polyacrylamide gels and radiolabeled species visualized with autoradiography as previously described (Cheresh, 1987) .
Adhesion Assay
Cell adhesion assays were performed as previously described with modifications (Wayner et al., 1991) . In brief, sterile, untreated, bacteriological-grade polystyrene 48-well cluster plates (Costal', Cambridge, MA) were coated at 4~ overnight with adhesive ligands (200/~t at 10/~g/rnl in PBS) and immediately before use blocked with 5% BSA in PBS, pH 7.4, Cells were harvested with trypsin/EDTA, washed once, and suspended in HBSS supplemented with 1% BSA, 1 mM CaCl2, 1 mM MgCl2, and 0.5 mM MnCl2 and then added to appropriate wells. Cells were permitted to adhere for various times at 37~C in 5 % COz in the presence or absence of purified mAbs specific for various integrins (50 ~g/ml) or the synthetic peptides (50 raM) GRGDSPK, and SPGDRGK. Norvadhercnt cells were removed with gentle washing and celt attachment enumerated from dye uptake. Adherent cells were fixed with 3% paraformaldehyde, stained with 0.1% crystal violet, air dried, and extracted in 10% acetic acid. Dye uptake was determined spectmphotometrically at 600 nm.
Cell spreading was evaluated before staining in the above adhesion assay and enumerated from random quadruplicate fields containing at least 100 cells.
Indirect ImmunoJtuorescence
Cells were allowed to attach and spread on vitronectin-or fibrinogen-coated glass coverslips and stained by indirect immunofluorescence as described (Wayner et al., 1991) . In brief, cells were fixed with 3 % paraformaldehyde, permeabilized with 10 mM Tris, pH 7.4, 150 mM NaCI, 1 mM CaCI2 containing 0.1% Triton X-100 for 1 min. Permeabilized cells were stained with mAb AP3 or antisera to human vitmnectin (60 rain at room temperature), washed and counter stained (60 rain at room temperature) with either rhodamine-conjugated goat anti-mouse IgG, or fluorescein-conjugated goat anti-rabbit IgG (Tago, Buriingame, CA). Focal adhesion plaques were visualized by the exclusion of vitronectin-specific antibody from the cell-substrate contacts as previously described OVayner et al., 1991) . Fluorescence was detected with a Photomicroscope (Carl Zciss, Oberkochen, Germany) fitted with epifluorescence.
Cell Migration Assay
Cell migration assays were performed using modified Boyden chambers with a 6.5-mm ditto, lO-~m thickness, porous (8.0/tin) polystyrene membrane separating the two chambers (Transwell| Costar). Soluble ligands (20 #g/ml) were placed in lower, migration chambers in 600 #1 of serumfree RPMI 1640 supplemented with 1% ITS+ (Collaborative Research, New Bedford, MA), 50 #g/ml gentamycin, 2.5 t~g/mi amphotericin B (Sigma Chemical Co.), and then incubated at 37~ for 30 rain before the addition of cells. Sub-confluem 24-h cultures were harvested with trypsin/ EDTA, washed once, and resuspended in the serum-free RPMI without adhesive ligends. Cells (50,000) were added in 100 v.t to the upper chamber in the presence or absence of the synthetic peptides (50 raM) GRGDSPK, SPGDRGK, or mAbs (50 ~tg/ml) to various integrins. Migration is measured after 48-h incubation at 37"C by counting the number of cells recovered from the floor of the lower chamber. Non-adherent cellular debris is removed with gentle washing and cells fixed with 3 % paraformaldehyde. Cell rni~ration was quantitated from photographs taken under phase contrast of quadruplicate, random fields from duplicate samples. Random (nonspecific) migration was determined using the control protein BSA (20 t~g/ mi). Specific cell migration toward each matrix protein was calculated by subtracting BSA-mediated migration from total cell migration. In each case random migration 67% of total matrix-dependent migration.
Results
FG human carcinoma cells fail to express mRNA encoding the integrin 83 subunit (Cheresh et al., 1989
). Thus we sought to determine the mechanism of FG cell attachment to vitronectin. FG cells were allowed to attach to vitronectinor collagen-coated wells in the presence or absence of mAbs specific for integrins olv/~3, av/35, and El. As shown in Table  I , FG cell attachment to vitronectin can be significantly inhibited (67%) with mAb P3G2 directed to integrin c~v/~5, while mAb LM609, directed to ~,vB3, or mAb P4C10, directed to the BI subunit, have little or no effect. These data indicate that cev~5 is the primary vitronecfin receptor expressed by FG cells. In contrast, mAbs LM609 and P3G2 have little or no effect on FG cell adhesion to collagen, whereas mAb P4C10 abolishes (91%) cell attachment on this substrate.
M21 human melanoma cells express otv/~3 as their primary vitronectin receptor (Wayner et al., 1991) . Therefore, as shown in Table I , mAb LM609 significantly inhibited M21 cell adhesion to this matrix by 60%, whereas mAb P3G2, specific for av~5, had a reduced effect (28%). The Bl-specific mAb, P4CIO, had minimal effect on M~21 cell attachment to vitronectin but completely inhibited attachment to collagen (97%), consistent with previous results (Strauss et al., 1989) . These results collectively demonstrate that FG carcinoma cell adhesion to vitronecfin is primarily mediated by ~xv~5 while M21 melanoma cell attachment to this ligand primarily involves o~v/~3.
To investigate the biological consequences of o~v/~3-or o~v/~5-dependent cell adhesion, we examined the capacity of FG cells or M21 cells to spread on vitronectin. As shown in Fig. 1 , FG cells readily attach to, but do not spread on this matrix, even after 90 rain. In contrast, these cells readily spread on a collagen matrix indicating that the intrinsic ability Of FG cells to spread is not deficient. M21 human melanoma cells, which use primarily o~vB3 to attach to vitronec- * FG or M21 cells were allowed to attach to vitronectin-or collagen (10 #g/ml)-coated wells in the presence or absence of mAbs (50 #g/ml) for 60 min at 370C as described in Materials and Methods. Standard deviations were routinely < 10%. * Represents percent inhibition of cell adhesion relative to adhesion in the absence of antibody.
View, CA); FG-B which expresses 133, and FG-A which fails to express 03. As shown in Fig. 2 , immunoprecipitation analysis of ~2q-surface-labeled FG transfectants reveals that both cell types express equivalent levels of avB5 and integrins, mAb LM609, directed to the wr complex, immunoprecipitates this receptor from the 133 expressing FG-B sub-line and not from the FG-A (mock transfected) sub-line. mAb LM142, directed to the we subunit, immunoprecipitates this subunit associated with multiple/3 subunits, including 05 and 06 (Busk et al., 1992 ). These results demonstrate that transfection of FG cells with a cDNA encoding the 03 integrin subunit results in the stable expression of cry/33 complexes at the cell surface. Moreover these immunoprecipitation profiles indicate that de novo expression of/3 3 in the FG-B population does not alter the expression of other otv-integrins, or Bl-integdns, which remain at equivalent levels in both cell populations.
tin, rapidly spread on this matrix (Fig. 1) . These data suggest that the homologous integrins otv03 and av05 mediate differential biological functions in response to a common ligand.
Transfection of FG Cells with 03 cDNA Results in the Expression of lntegrin avfl3
To determine whether the inability of FG cells to spread on vitronectin is a result of the specific absence of integrin av/33, FG cells were transfeeted with an expression vector containing eDNA encoding the human/33 integrin subunit and a gene for neomycin resistance. After drug selection, two stable transfectant FG sub-lines were established from populations sorted for av/33 expression using FACS (a registered trademark of Becton Dickinson & Co., Mountain
Expression of/33 in FG Cells Alters Their Biological Response to Vitronectin and Fibrinogen
To establish whether FG-B cells express the o~v03 integrin in a functional form, cell adhesion assays were performed.
FG-A and FG-B cells attach to vitronectin yet only FG-B cells can be inhibited with mAb LM609, directed to wr (55 %, not shown). This adhesion event results in FG-B cell
spreading on both vitronectin (Fig. 3 , A-C) and fibrinogen ( Fig. 3 B,/eft) within 60 min. In contrast, the/33 negative, parental FG cells (Fig. 1) filament cytoskeleton leading to cell spreading on a vitronectin or fibrinogen matrix. Approximately 40% of the FG-B cell population express/~3 and only these cells were found to spread on vitronectin or fibrinogen. In addition, mAb LM609 prevents cell spreading on vitronectin or fibrinogen providing further evidence for a role for o~v/33 in this process (data not shown).
To further investigate the biological role of integrin av/~3 we examined the capacity of this receptor to potentiate FG-B cell migration. For these experiments we used modified Boyden chambers containing an 8.0 ~,m porous membrane. FG cells do not demonstrate significant or specific migration through the 8.0 ~m pores separating these chambers in the presence of the control ligand BSA. However, both FG-A and FG-B cells readily migrate toward a collagen source yet only FG-B cells, expressing av/33, are capable of migrating toward vitronectin or fibrinogen (Fig. 4) . FG-B cell migration to both vitronectin and fibrinogen is completely inhibited by mAb LM609 demonstrating that av/33 is responsible for this event (Fig. 4) . In contrast, mAb P3G2, directed to ave5, had no effect on FG-A or FG-B cell migration to all substrata tested (data not shown), indicating this receptor fails to potentiate migration of these cells. In addition an RGDcontaining synthetic peptide which functionally inhibits czv/33-mediated cell attachment (Cheresh et al., 1989) , completely blocks av/~3-dependent migration (data not shown). It is of interest that the migration of av/~3-expressing FG-B cells toward collagen is not significantly inhibited by mAb P4C10, directed to /31 integrins, suggesting an additional mechanism in these cells (Fig. 4) . In fact, integrin av/~3 has been reported, in some cells, to recognize collagen (Kramer et al., 1990) suggesting that, in addition to vitronectin and fibrinogen, av/33, when present, may also contribute to collagen-dependant cell migration.
Discussion
This study was designed to characterize the biological properties of two structurally and functionally related integrins avfl3 and avfl5 which are often expressed on the same cell The Journal of Cell Biology, Volume I17, 1992 Figure 3 . Expression of ~3 promotes FG-B cell attachment and spreading on vitronectin and fibrinogen with ~3 localization to focal contacts. /~3-Transfected FG-B cells were allowed to attach and spread on vitronectin-coated coverslips for 60 rain. Nonadherent cells were removed with gentle washing and attached ceils evaluated for spreading with phase-contrast microscopy (,4). For fluorescence experiments FG-B cells were allowed to attach and spread on vitronectin-or fibrinogen-coated coverslips, fixed, permeabilized, and stained with mAb AP3 directed to the/53 integrin subunit, or anti-sera to vitronectin (B and C, respectively)./53 staining in cells spread on fibrinogen (B,/eft) and vitronectin (B, center and right) exactly co-distributes with focal contacts, visualized by the exclusion of vitronectin-specific antibody from the cellsubstrate contacts as described under Materials and Methods (C, ~3, left; anti-vitronectin, right; arrows, co-localized staining). Representative cells were photographed with a Zeiss microscope fitted with epifluorescence. Bars: (A) 25 tam; (8 and C) 10 tam. (Wayner et al., 1991) . These receptors bind vitronectin in an RGD-dependent manner, contain identical a subunits and structurally similar fl subunits (Cheresh and Spiro, 1987; Cheresh et al., 1989; McLean et al., 1990; Ramaswamy and Hemler, 1990; Suzuki et al., 1990) . However, the cytoplasmic tails of/33 and t5 are structurally distinct thus raising the possibility that avfl3 and c~vfl5 mediate differential biological signals in response to vitronectin.
In this report we provide several lines of evidence that these integrins mediate distinct biological responses to a vitronectin substrate. Firstly, FG carcinoma cells use avfl5 as their major vitronectin receptor since they fail to express /33 mRNA or protein (Cheresh et al., 1989) and attach but fail to spread on vitronectin and are incapable of attaching to fibrinogen. This is not because of a general deficiency in FG cell spreading since these cells readily attach and spread on collagen in an integrin El-dependent manner. Secondly, M21 cells, which express a, vfl3 as their major vitronectin receptor (Wayner et al., 1991) , attach and spread on both vitronectin and fibrinogen with ocv~3 expressed in focal contacts at the end of actin filament bundles (Wayner et al., 1991) . Thirdly, transfection of/33 negative FG cells with a cDNA encoding t3 results in the surface expression of avfl3 which enables these cells to spread on vitronectin and fibrinogen. Moreover,/33 localizes to focal contacts on these transfected FG cells indicating that otvfl3 is directly involved in cell spreading on these matrix proteins. Finally, FG-B cells expressing the 83 gene product not only spread, but acquire the ability to migrate in response to vitronectin and fibrinogen. That this is because of the presence of uv~3 on these cells is demonstrated by the ability of mAb LM609 (anti-otvfl3) or an RGD-containing peptide to block this migration. These results provide a rationale for the expression of uvfl3 and avfl5 on the same cell where oecfl5 promotes simple adhesion while av~3 enables cells to modify their shape and mobility on vitronectin.
Although o~vfl5 is the major vitronectin-binding integrin on FG cells we cannot completely exclude the possibility that additional vitronectin-binding integrins are expressed on these cells other than a, vfl3. For example, integrin av~l ap- Figure 4 . Antibody-specific inhibition of FG carcinoma cell migration. Vitronectin, collagen, and fibrinogen (20 t~g/ml) in serum-free medium were placed into the lower chamber of a modified Boyden chamber separated by an 8.0 ttm porous membrane from FG-A (n) or FG-B (I) cells placed into the upper chamber in the absence (Control) or presence of mAbs LM609 (anti-c~v/~3) or P4C10 (anti-/~1). Migratory cells which had traversed the membrane into the lower chamber were counted (mean of four random fields + SE) after 45-h incubation at 37"C. Random, non-specific migration (when BSA is placed into the lower chamber) has been subtracted, was ~7% of the total migration in response to any substrate. parently mediates vitronectin adhesion of certain ceils . It is conceivable that c,v/31 could play a minor role in FG cell and M21 cell attachment to vitronectin since mAb P4C10 directed to/31 partially inhibited the attachment of both cell types to vitronectin (,,020%). However, immunoprecipitation analysis failed to detect otv/31 on either cell type. In any event the expression of c~v/31 or another vitronectin-binding integrin on FG cells does not account for measurable cell spreading and/or migration on vitronectin.
The cytoplasmic tail of the/35 subunit is structurally distinct from those of the/31 and/33 subunits (Ramaswamy and Hemler, 1990; McLean et al., 1990; Suzuki et al., 1990 ) and thus may be responsible for a distinct signal transduction event. Alternatively, it is conceivable that this subunit is simply incapable of interacting with one or more cytoplasmic proteins thought to be involved in the assembly of focal contacts. For example, talin and o~-actinin, two proteins found in focal contacts, have been shown to directly bind integrins . In fact, o~-actinin directly binds to a peptide derived from the cytoplasmic tail of/31 . Based on a mutational analysis of the/51 integrin it appears that the structural basis of integfin focal contact formarion depends on three domains with the cytoplasmic tail of/31 (Reszka and Horowitz, 1992) . It is noteworthy that/31 and/33 are extremely well conserved in each of these regions while/35 has virtually no sequence homology in the most COOH-terminal of these domains. It is conceivable that specific residues within this particular domain fail to support the localization of o~v/35 into focal contacts. To test this hypothesis it will be necessary to examine the expression of truncated and/or chimeric integrin heterodimers in cells that normally fail to form focal contacts on a vitronectin substrate. It is also interesting to note that the cytoplasmic tail of/35 contains five serine residues not found in/31 or/33 (Ramaswamy and Hemler, 1990; McLean et al., 1990; Suzuki et al., 1990) . Perhaps phosphorylation of one or more of these prevents the localization of t~v/35 to focal contacts. In fact, the/3s subunit which may be related or identical to/35 becomes phosphorylated on serine in response to activators of protein kinase C (Freed et al., 1989) .
The differential ability of cry/33 and oev/35 to promote cell spreading and migration may have profound biological implications during events associated with development, wound healing, and neoplasia where cell migration is known to take place. Thus, the genetic regulation of/33 and/35 may play a key role in determining the migratory status of a cell. Recent evidence supports this hypothesis. Non-differentiated keratinocytes, which are known to be migratory, express both av/33 and o~v/35 integrins while terminally differentiated keratinocytes, which do not migrate, no longer express 0o~/33 (Adams and Watt, 1991) . Furthermore, the/33 subunit expressed by sub-confluent embryonic lung fibroblasts, is down regulated when these cells reach confluence (Bates et al., 1991) . The role of o~v/33 in melanoma cell migration may be very relevant for the metastatic phenotype of these cells. In fact, 0~v/33 was found to be preferentially expressed on metastatic and vertically invasive primary lesions whereas it was not detected on normal melanocytes, nevi, or horizontal primary melanoma (Albelda et al., 1990) . The promiscuous ligand-binding capacity of oLv/33 suggests that ceils expressing this receptor can migrate on a wide variety of matrices and basement membranes. Our results demonstrate that fibrinogen a known ligand for c~v/33 (Cheresh, 1987) can promote the migration of/3 3 transfected FG cells. Therefore the expression of r and the resulting phenotype may play an important role in a wide range of migratory events involving multiple biological phenomena.
